Search filters

List of works by Christine Sekaggya-Wiltshire

A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients

scientific article published on 16 January 2019

A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa

scientific article published on 29 January 2020

A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study

scientific article published in 2023

Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.

scientific article published on 19 January 2017

Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control study

scientific article published on 06 December 2019

Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda

scientific article published in 2023

Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study.

scientific article published on 18 September 2017

Comparison of Löwenstein-Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV

article

Delayed Sputum Conversion in TB-HIV Co-Infected Patients with Low Isoniazid and Rifampicin Concentrations.

scientific article published on 3 March 2018

Detection of tuberculosis patterns in digital photographs of chest X-ray images using Deep Learning: feasibility study

scientific article published in March 2018

Developing and validating a clinical warfarin dose-initiation model for Black-African patients in South Africa and Uganda

scientific article published on 06 December 2020

Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis

scientific article

Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis

scientific article published on 21 November 2017

Erratum for Sekaggya-Wiltshire et al., "Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?"

scientific article published on 24 March 2020

Factors associated with isoniazid preventive treatment interruption and completion among PLHIV in Gombe Hospital, Uganda, 2017–2019

scientific article published in 2023

HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic

article

High efavirenz serum concentrations in TB/HIV-coinfected Ugandan adults with a CYP2B6 516 TT genotype on anti-TB treatment

article

Importance of routine viral load monitoring: higher levels of resistance at ART failure in Uganda and Lesotho compared with Switzerland

scientific article published on 01 February 2019

Increasing retention of HIV positive pregnant and breastfeeding mothers on option-b plus by upgrading and providing full time HIV services at a lower health facility in rural Uganda

scientific article published on 15 July 2019

Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?

scientific article published on 24 May 2019

Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda

scientific article

Optimal therapy for multidrug-resistant tuberculosis and HIV

scientific article published on 01 August 2020

Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis

scientific article published on 30 July 2019

Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)

scientific article published on 13 February 2020

Sensitivity and specificity of the mean corpuscular volume and CD4/CD8 ratio in discriminating between rifampicin resistant and rifampicin sensitive tuberculosis

scientific article published on 23 November 2020

Sustained positive impact on tuberculosis treatment outcomes of TB-HIV integrated care in Uganda

scientific article published on 01 April 2019

Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort

scientific article published in PLoS ONE

The Impact of Chronic Pulmonary Aspergillosis Co-infection on the Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Uganda

scientific article published in 2023

The Influence of Pharmacogenetic Variants in HIV/Tuberculosis Coinfected Patients in Uganda in the SOUTH Study

scientific article published on 29 March 2019

The utility of pharmacokinetic studies for the evaluation of exposure-response relationships for standard dose anti-tuberculosis drugs

scholarly article by Christine Sekaggya-Wiltshire et al published January 2018 in Tuberculosis

Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study

scientific article

Utility of the monocyte to lymphocyte ratio in diagnosing latent tuberculosis among HIV-infected individuals with a negative tuberculosis symptom screen

scientific article published on 09 November 2020

Virological Outcome of Patients With HIV Drug Resistance Attending an Urban Outpatient Clinic in Uganda: A Need for Structured Adherence Counseling and Third-Line Treatment Options

scientific article published on 01 April 2019

“It is not easy”: Experiences of people living with HIV and tuberculosis on Tuberculosis treatment in Uganda

scientific article published in 2023